Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.
about
Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical ExperienceThe Impact of Accelerometer and Heart Rate Data on Hypoglycemia Mitigation in Type 1 DiabetesHeart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D.Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus.Modular closed-loop control of diabetesOvernight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.Closed-loop insulin delivery utilizing pole placement to compensate for delays in subcutaneous insulin deliveryAnticipating the next meal using meal behavioral profiles: a hybrid model-based stochastic predictive control algorithm for T1DM.Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 DiabetesEarly pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes.Analyte flux at a biomaterial-tissue interface over time: implications for sensors for type 1 and 2 diabetes mellitus.New-generation diabetes management: glucose sensor-augmented insulin pump therapy.The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wearAccelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidaseUndeniable need for ultrafast-acting insulin: the pediatric perspectiveClosed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial.Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device.Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming.Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements?Treatment options for paediatric diabetes.The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences.Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusionMoving toward the ideal insulin for insulin pumps.Sources of glycemic variability--what type of technology is needed?Real-time estimation of plasma insulin concentration from continuous glucose monitor measurements.Boluses in Insulin Therapy.Mathematical modeling research to support the development of automated insulin-delivery systemsUpdate on mathematical modeling research to support the development of automated insulin delivery systems.Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same?Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time.Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine.Improved pharmacokinetic and pharmacodynamic profiles of insulin analogues using InsuPatch, a local heating device.
P2860
Q28085428-1AF9F45B-B240-45AD-9615-75B5D9B54A22Q28395448-A8D7B8D8-DB2E-4690-8257-CD239C748B25Q30275746-170B2ADF-AABF-480A-B783-3502BCE3A99FQ30301357-3A2213EE-3CC6-4BE1-8BDF-8473E9376D2EQ30370427-AD0DA2A2-F025-4265-90D1-0A1FF820A109Q30371580-3376DD7C-9CC8-4A12-83D3-B5776944A4C5Q30424297-5985510F-FE1E-45A1-B21A-399353DDE55BQ30427062-9510F1EB-9B87-4566-BC3B-2F128480C47AQ31121925-74B3164D-3432-4945-83E2-1DA70EBB47DFQ33804562-FC98CDF0-369F-4189-8D2C-E443B8B746BCQ34209072-FB696E66-B34A-4253-990A-481C9BBC46BAQ35224968-974AAD00-FA36-42BA-AC64-51FF075073ACQ35841209-355B32C2-B0DC-4362-9BA2-D29590A83724Q35929406-BB596CB7-C3DE-444C-9066-D6AD7E0A9126Q36229271-3A3A1E69-75F4-4135-8019-1CD8EBB9F21AQ36229282-15ADC0D0-08FC-4FB6-B9CE-1665B2DA6424Q36560323-E5837FE0-48A3-4F0C-9DAE-8214842846BDQ36609298-583086C9-FACE-444A-A53F-C336D9FCC2F8Q37404470-17F8F06C-E3BD-407D-8795-5CB9FDBBECF9Q37460129-5D1FBA0E-2FE1-4A94-9546-1C88487AB874Q37689902-9C7B7107-5EC7-4376-8FC5-A41C17B405DAQ37776269-BD1A5606-AE3B-4CC7-B702-409C3EE852B9Q37982891-9D74F640-80A0-496E-823B-E61245248341Q38037730-F36911EA-D50A-4342-A17C-10357D8DD067Q38631154-81056566-58BA-4C52-B166-3071ACDDD583Q39902171-FC45E641-608D-402C-96AD-D71528462DADQ40569379-64CCFB95-110D-45FC-AF13-A86888B0430DQ42293182-56A4BDF2-D9B2-43A0-9A6D-90BE1428FED3Q42607729-F61E0E86-1645-409D-83B5-C1A41373D9A5Q42735600-1EBBF36A-C5F8-46A8-814F-F4FC22D081F0Q42959127-822E8BF2-C64C-43F7-8776-97B956F14D20Q43094790-DDDBBA09-0A97-48A4-A489-637C9A268ED1Q45834106-2271C9FD-B6B6-48D9-B15A-76E1A341D09DQ53603000-2F6BD6FD-88E4-4CC1-BEE4-A37A1470DAB5
P2860
Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Effect of age of infusion site ...... eceiving insulin pump therapy.
@en
Effect of age of infusion site ...... eceiving insulin pump therapy.
@nl
type
label
Effect of age of infusion site ...... eceiving insulin pump therapy.
@en
Effect of age of infusion site ...... eceiving insulin pump therapy.
@nl
prefLabel
Effect of age of infusion site ...... eceiving insulin pump therapy.
@en
Effect of age of infusion site ...... eceiving insulin pump therapy.
@nl
P2093
P2860
P356
P1433
P1476
Effect of age of infusion site ...... eceiving insulin pump therapy.
@en
P2093
Amy T Steffen
Garry M Steil
Gayane R Voskanyan
James D Dziura
Karena L Swan
Kristin A Sikes
Melody L Martin
Stuart A Weinzimer
P2860
P304
P356
10.2337/DC08-0595
P407
P577
2008-11-18T00:00:00Z